Cumulative studies have demonstrated that the SCF E3 ubiquitin ligase family acts as an important regulator of post-translational modification and is closely associated with cardiovascular diseases such as cardiac hypertrophy, myocardial infarction, arrhythmia, and myocardiotoxicity [26, 27]. Here, KITLG is linked to myocardial infarction.